September 13 - 16, 2010    Arlington VA , USA
Research of the molecular mechanisms of cancer, which is a complex disease, has recently benefitted from advanced “omic” and cellular technologies, providing scientists with new opportunities for diagnostic and therapeutic development. The Translational Cancer Medicine track of ADAPT 2010 Congress focuses on three of these opportunities: 1. Using circulating tumor cells as markers for disease prognosis and treatment selection; 2. Understanding cancer stem cell mechanism toward development of novel therapeutics; and 3. Extracting novel targets and biomarkers from the cancer genome.

Venue

Location: Hyatt Regency Crystal City
Success is ensured when you entrust your business functions to the experts at Hyatt Regency Crystal City at Reagan National Airport. Boasting some of the largest Washington DC area meeting facilities..
Contact 2799 Jefferson Davis Hwy., Ave. at Old Georgetown Rd. Arlington , USA
+1 703 418 1234

Related events

CHI’S Translational Cancer Medicine September 19 - 21, 2012
CHI’S Translational Cancer Medicine September 24 - 25, 2011
CHI’S Translational Cancer Medicine September 13 - 16, 2010